|
1
|
Matzinger M, Fischhuber K and Heiss EH:
Activation of Nrf2 signaling by natural products-can it alleviate
diabetes? Biotechnol Adv. Dec 28–2017.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stoffers DA: The development of beta-cell
mass: recent progress and potential role of GLP-1. Horm Metab Res.
36:811–821. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tourrel C, Bailbe D, Lacorne M, Meile MJ,
Kergoat M and Portha B: Persistent improvement of type 2 diabetes
in the Goto-Kakizaki rat model by expansion of the beta-cell mass
during the prediabetic period with glucagon-like peptide-1 or
exendin-4. Diabetes. 51:1443–1452. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sakuraba H, Mizukami H, Yagihashi N, Wada
R, Hanyu C and Yagihashi S: Reduced beta-cell mass and expression
of oxidative stress-related DNA damage in the islet of Japanese
Type II diabetic patients. Diabetologia. 45:85–96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marchetti P, Del Guerra S, Marselli L,
Lupi R, Masini M, Pollera M, Bugliani M, Boggi U, Vistoli F, Mosca
F and Del Prato S: Pancreatic islets from type 2 diabetic patients
have functional defects and increased apoptosis that are
ameliorated by metformin. J Clin Endocrinol Metab. 89:5535–5541.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cozar-Castellano I, Fiaschi-Taesch N,
Bigatel TA, Takane KK, Garcia-Ocaña A, Vasavada R and Stewart AF:
Molecular control of cell cycle progression in the pancreatic
beta-cell. Endocr Rev. 27:356–370. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirschey MD: Old enzymes, new tricks:
Sirtuins are NAD(+)-dependent de-acylases. Cell Metab. 14:718–719.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Colak G, Xie Z, Zhu AY, Dai L, Lu Z, Zhang
Y, Wan X, Chen Y, Cha YH, Lin H, et al: Identification of lysine
succinylation substrates and the succinylation regulatory enzyme
CobB in Escherichia coli. Mol Cell Proteomics. 12:3509–3520. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park J, Chen Y, Tishkoff DX, Peng C, Tan
M, Dai L, Xie Z, Zhang Y, Zwaans BM, Skinner ME, et al:
SIRT5-mediated lysine desuccinylation impacts diverse metabolic
pathways. Mol Cell. 50:919–930. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rardin MJ, He W, Nishida Y, Newman JC,
Carrico C, Danielson SR, Guo A, Gut P, Sahu AK, Li B, et al: SIRT5
regulates the mitochondrial lysine succinylome and metabolic
networks. Cell Metab. 18:920–933. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weinert BT, Scholz C, Wagner SA,
Iesmantavicius V, Su D, Daniel JA and Choudhary C: Lysine
succinylation is a frequently occurring modification in prokaryotes
and eukaryotes and extensively overlaps with acetylation. Cell Rep.
4:842–851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Z, Tan M, Xie Z, Dai L, Chen Y and
Zhao Y: Identification of lysine succinylation as a new
post-translational modification. Nat Chem Biol. 7:58–63. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hirschey MD and Zhao Y: Metabolic
regulation by lysine malonylation, succinylation, and
glutarylation. Mol Cell Proteomics. 14:2308–2315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan M, Peng C, Anderson KA, Chhoy P, Xie
Z, Dai L, Park J, Chen Y, Huang H, Zhang Y, et al: Lysine
glutarylation is a protein posttranslational modification regulated
by SIRT5. Cell Metab. 19:605–617. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie Z, Dai J, Dai L, Tan M, Cheng Z, Wu Y,
Boeke JD and Zhao Y: Lysine succinylation and lysine malonylation
in histones. Mol Cell Proteomics. 11:100–107. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
American Diabetes Association. Diagnosis
and classification of diabetes mellitus. Diabetes Care. 35 Suppl
1:S64–S71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fujimoto K and Polonsky KS: Pdx1 and other
factors that regulate pancreatic beta-cell survival. Diabetes Obes
Metab. 11 Suppl 4:S30–S37. 2009. View Article : Google Scholar
|
|
19
|
Manaka K, Nakata M, Shimomura K, Rita RS,
Maejima Y, Yoshida M, Dezaki K, Kakei M and Yada T: Chronic
exposure to valproic acid promotes insulin release, reduces KATP
channel current and does not affect Ca (2+) signaling in mouse
islets. J Physiol Sci. 64:77–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Axelsson AS, Mahdi T, Nenonen HA, Singh T,
Hänzelmann S, Wendt A, Bagge A, Reinbothe TM, Millstein J, Yang X,
et al: Sox5 regulates beta-cell phenotype and is reduced in type 2
diabetes. Nat Commun. 8:156522017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weir GC and Bonner-Weir S: Five stages of
evolving beta-cell dysfunction during progression to diabetes.
Diabetes. 53 Suppl 3:S16–S21. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ashcroft FM and Rorsman P: Diabetes
mellitus and the β cell: The last ten years. Cell. 148:1160–1171.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kumar S and Lombard DB: Mitochondrial
sirtuins and their relationships with metabolic disease and cancer.
Antioxid Redox Signal. 22:1060–1077. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu J, Sadhukhan S, Noriega LG, Moullan N,
He B, Weiss RS, Lin H, Schoonjans K and Auwerx J: Metabolic
characterization of a Sirt5 deficient mouse model. Sci Rep.
3:28062013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakagawa T, Lomb DJ, Haigis MC and
Guarente L: SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and
regulates the urea cycle. Cell. 137:560–570. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qadir MI and Anwar S: Sirtuins in brain
aging and neurological disorders. Crit Rev Eukaryot Gene Expr.
27:321–329. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu W, Zuo Y, Feng Y and Zhang M: SIRT5
facilitates cancer cell growth and drug resistance in non-small
cell lung cancer. Tumour Biol. 35:10699–10705. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gannon M, Gamer LW and Wright CV:
Regulatory regions driving developmental and tissue-specific
expression of the essential pancreatic gene pdx1. Dev Biol.
238:185–201. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Spaeth JM, Gupte M, Perelis M, Yang YP,
Cyphert H, Guo S, Liu JH, Guo M, Bass J, Magnuson MA, et al:
Defining a novel role for the Pdx1 transcription factor in islet
β-cell maturation and proliferation during weaning. Diabetes.
66:2830–2839. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujitani Y: Transcriptional regulation of
pancreas development and β-cell function [Review]. Endocr J.
64:477–486. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang
H, Kim J, Woo J, Kim JH, Choi BH, et al: Sirt5 is a NAD-dependent
protein lysine demalonylase and desuccinylase. Science.
334:806–809. 2011. View Article : Google Scholar : PubMed/NCBI
|
